In the future, it will also be possible to co-culture MINDY1-overexpressing tumor cells with CD8+ T cells and treat them with PD-L1 blocking antibodies to verify whether changes in the ubiquitinylation status of PD-L1 directly affect the function of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.